Eagle Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Eagle Pharmaceuticals's balance sheet done over the years? Its assets were worth $406,160,000 last year, which is more than in the previous period. 42% of Eagle Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $172,600,000, which means an increase by 123% compared compared to last year.
Debt to Assets
| 2013 | 18102620 | 16.04M | 88.65% |
|---|---|---|---|
| 2014 | 53411000 | 20.31M | 38.04% |
| 2015 | 124605000 | 34.26M | 27.5% |
| 2016 | 213570000 | 62.34M | 29.19% |
| 2017 | 270060000 | 90.91M | 33.67% |
| 2018 | 238603000 | 77.84M | 32.62% |
| 2019 | 254554000 | 75.38M | 29.61% |
| 2020 | 253190000 | 67.17M | 26.53% |
| 2021 | 253732000 | 77.27M | 30.46% |
| 2022 | 406160000 | 172.6M | 42.5% |
EGRX Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 55.32M | 97.65M | 103.15M | 109.77M | 78.79M | 114.65M | 52.82M | 79.08M | 22.72M | 10.45M |
Short term investments | 0 | 4.98M | 0 | 0 | 0 | 0 | 0 | 0 | 19.99M | 0 |
Net receivables | 72.43M | 41.14M | 51.11M | 48.00M | 66.48M | 53.82M | 42.19M | 26.26M | 7.29M | 5.12M |
Inventory | 47.79M | 21.90M | 8.07M | 6.56M | 8.30M | 5.11M | 2.73M | 15.04M | 1.29M | 1.87M |
Other current assets | 13.2M | 11.89M | 1.60M | 15.10M | 10.26M | 29.64M | 11.35M | 3.51M | 1.71M | 31.85K |
Total current assets | 188.75M | 172.60M | 166.06M | 179.44M | 163.84M | 188.69M | 109.11M | 122.25M | 53.02M | 17.48M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.16M | 1.63M | 2.07M | 2.20M | 2.39M | 6.82M | 3.31M | 2.20M | 344K | 402.28K |
Goodwill | 45.03M | 39.74M | 39.74M | 39.74M | 39.74M | 39.74M | 39.74M | 0 | 0 | 0 |
Intangible assets | 118.32M | 10.67M | 12.91M | 15.58M | 18.10M | 23.32M | 32.62M | 0 | 0 | 0 |
Long term investments | 10.01M | 6.03M | 12.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 15.72M | 4.24M | 5.00M | 3.90M | 694K | 124K | 136K | 143K | 45K | 217.92K |
Total non-current assets | 217.40M | 81.12M | 87.12M | 75.10M | 74.75M | 81.36M | 104.46M | 2.34M | 389K | 620.21K |
Total assets | 406.16M | 253.73M | 253.19M | 254.55M | 238.60M | 270.06M | 213.57M | 124.60M | 53.41M | 18.10M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 25.36M | 20.74M | 26.06M | 21.71M | 15.39M | 0 | 6M | 6.58M | 10.01M |
Short term debt | 6.25M | 25.60M | 8M | 5M | 6.25M | 4.87M | 0 | 0 | 0 | 3.06M |
Total current liabilities | 111.08M | 74.37M | 38.08M | 38.82M | 39.68M | 47.30M | 40.21M | 34.26M | 20.31M | 14.34M |
| Non-current liabilities: | ||||||||||
Long term debt | 56.21M | 2.90M | 29.09M | 33.55M | 38.15M | 42.90M | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 5.29M | -1K | 3.95M | 3M | -687K | 709K | 22.12M | 0 | 0 | 1.70M |
Total non-current liabilities | 61.51M | 2.90M | 29.09M | 36.55M | 38.15M | 43.61M | 22.12M | 9.85M | 10.64M | 1.70M |
Total liabilities | 172.6M | 77.27M | 67.17M | 75.38M | 77.84M | 90.91M | 62.34M | 34.26M | 20.31M | 16.04M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |